Posted on

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

Together with the previously announced Talicia strategic divestiture, the acquisition from Ferring of commercialization rights to two larger, proprietary, established gastrointestinal (GI) FDA-approved drugs that together generated approximately $37.5 million in 2025 net sales, completes a major strategic repositioning of RedHill’s commercial GI business

By sf-admin
Posted on

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) — – Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire eCential Robotics, a leading developer of enabling technologies and surgical robotics. The acquisition expands the ASTRA™ enabling technology platform with robotic automation capabilities, creating a more comprehensive ecosystem designed to improve surgical precision, streamline workflows, and enhance patient outcomes. 

By sf-admin
Posted on

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) —

Stryker (NYSE:SYK), a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and developer of the FiberLocker® System. This commercialized technology provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.

By sf-admin
Posted on

Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement Therapy

The Canadian Vaping Association calls on Health Canada to align with the world’s most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit 

The Canadian Vaping Association calls on Health Canada to align with the world's most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit

By sf-admin
Posted on

BrandSafway Recognized with Two Project Awards from Scaffold Access and Industry Association (SAIA)

Top Specialty Contractor Wins Industry Recognition for Historic Contributions to Hangar One at Moffett Federal Airfield and US 181 Harbor Bridge, the Longest Cable-Stayed Bridge in the United States 

Top Specialty Contractor Wins Industry Recognition for Historic Contributions to Hangar One at Moffett Federal Airfield and US 181 Harbor Bridge, the Longest Cable-Stayed Bridge in the United States

By sf-admin
Posted on

Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight

The nontuberculous mycobacterial infections Market is expected to experience notable growth in the coming years, driven by the increasing prevalence and improved diagnosis of NTM infections, particularly among aging populations and individuals with underlying respiratory conditions. Additionally, the expected launch of emerging therapies such as Omadacycline (NUZYRA; Paratek Pharmaceuticals), MRX-5 (MicuRx Pharmaceuticals), Epetraborole (AN2 Therapeutics), RHB-204 (Redhill Biopharma), and others will further propel market growth. 

The nontuberculous mycobacterial infections Market is expected to experience notable growth in the coming years, driven by the increasing prevalence and improved diagnosis of NTM infections, particularly among aging populations and individuals with underlying respiratory conditions. Additionally, the expected launch of emerging therapies such as Omadacycline (NUZYRA; Paratek Pharmaceuticals), MRX-5 (MicuRx Pharmaceuticals), Epetraborole (AN2 Therapeutics), RHB-204 (Redhill Biopharma), and others will further propel market growth.

By sf-admin